Control Strategy and Analytical Methods for Small Molecule Impurities in ADCs

Antibody-drug conjugates (ADCs) are a class of innovative biopharmaceutical drugs. A typical ADC therapy is based on combining a monoclonal antibody (mAb) that is selective to tumor-associated antigens with an active payload via a linker.